Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Theresa LaValle"'
Autor:
Saad Yousuf, MeiLi Duan, Erika L Moen, Sam Cross-Knorr, Kate Brilliant, Benjamin Bonavida, Theresa LaValle, Kam C Yeung, Fahd Al-Mulla, Eugene Chin, Devasis Chatterjee
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e92478 (2014)
Raf kinase inhibitor protein (RKIP) is a member of the phosphatidylethanolamine-binding-protein (PEBP) family that modulates the action of many kinases involved in cellular growth, apoptosis, epithelial to mesenchymal transition, motility, invasion a
Externí odkaz:
https://doaj.org/article/ea33464ad2a441339bd70c05faec7e94
Autor:
Sheng Yao, Sruthi Ravindranathan, Theresa LaVallee, Sanjay D Khare, Narendiran Rajasekaran, Patricia Keegan, Xiaoguang Wang, Daniel J Chin, Su-Yi Tseng, Scott Klakamp, Kate Widmann, Varun Kapoor, Vladimir Vexler
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/be6e03e567ca486f9b68f511ad6c41df
Autor:
Jeffrey Sosman, Elad Sharon, Theresa LaVallee, Hussein A Tawbi, Ryan J Sullivan, Harriet M Kluger, Naiyer A Rizvi, David Feltquate
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 7 (2023)
The need for solid clinical definitions of resistance to programmed death 1 or its ligand (PD-(L)1) inhibitors for clinical trial design was identified as a priority by the Society for Immunotherapy of Cancer (SITC). Broad consensus efforts have prov
Externí odkaz:
https://doaj.org/article/b4ec42c072fc44199e543822100f2358
Autor:
Harriet Kluger, Omid Hamid, Roberta Zappasodi, Michael Hurwitz, Hussein Tawbi, Elad Sharon, Theresa LaVallee, Rebecca A Moss, Justin F Gainor, J Carl Barrett, Ryan J Sullivan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 3 (2023)
Immunotherapy is the standard of care for several cancers and the field continues to advance at a rapid pace, with novel combinations leading to indications in an increasing number of disease settings. Durable responses and long-term survival with im
Externí odkaz:
https://doaj.org/article/6400d9b9bb3148028d7abaef119802cc
Autor:
Paolo A. Ascierto, Lisa H. Butterfield, Olivera J. Finn, Andrew Futreal, Omid Hamid, Theresa LaVallee, Michael A. Postow, Igor Puzanov, Jeffrey Sosman, Bernard A. Fox, Patrick Hwu
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-13 (2022)
Abstract As part of the 2021 Immunotherapy Bridge virtual congress (December 1–2, Naples, Italy), the Great Debate sessions featured experts who were assigned counter opposing views on four important questions in immunotherapy today. The first topi
Externí odkaz:
https://doaj.org/article/b62868dd06ff48669cf032113f06cffc
Autor:
Eugene Chin, MeiLi Duan, Sam Cross-Knorr, Erika L. Moen, Benjamin Bonavida, Fahd Al-Mulla, Saad Yousuf, Theresa LaValle, Devasis Chatterjee, Kate E. Brilliant, Kam C. Yeung
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 3, p e92478 (2014)
PLoS ONE, Vol 9, Iss 3, p e92478 (2014)
Raf kinase inhibitor protein (RKIP) is a member of the phosphatidylethanolamine-binding-protein (PEBP) family that modulates the action of many kinases involved in cellular growth, apoptosis, epithelial to mesenchymal transition, motility, invasion a
Autor:
Antoni Ribas, Paul Chapman, Katherine S Panageas, Michael Postow, Joyson Karakunnel, Hussein Tawbi, Christine Spencer, Katy Tsai, Ramy Ibrahim, Jedd Wolchok, Theresa LaVallee, Travis J Hollmann, Alexander Shoushtari, Daniel K Wells, Margaret Callahan, Samantha Bucktrout, Claire F Friedman, Christopher R Cabanski, Pier Gherardini, Richard O Chen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/53029230391949998c537d2be9d8cb9c
Autor:
Sarah Warren, Jason Reeves, Christine Spencer, Travis Hollman, Claire Friedman, Theresa LaVallee, Tim Howes, Danny Wells
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/5919283a5e9f444681479b63634c4919
Autor:
Jiaqi Huang, Chris Morehouse, Katie Streicher, Brandon W Higgs, Jin Gao, Meggan Czapiga, Anmarie Boutrin, Wei Zhu, Philip Brohawn, Yong Chang, Jaye Viner, Theresa LaVallee, Laura Richman, Bahija Jallal, Yihong Yao
Publikováno v:
PLoS ONE, Vol 6, Iss 10, p e26177 (2011)
PURPOSE: Insulin-like growth factor (IGF) signaling through human insulin receptor isoform A (IR-A) contributes to tumorigenesis and intrinsic resistance to anti-IGF1R therapy. In the present study, we (a) developed quantitative TaqMan real time-PCR-
Externí odkaz:
https://doaj.org/article/bbcf5b03c12049078f8d5f6ebd89e2ef